Latest Antigen Stories
PROVIDENCE, R.I., Oct.
WORCESTER, Mass. and TORONTO, Oct.
Full Article Here: http://bit.ly/CHOPPI_PR PROVIDENCE, R.I., July 8, 2014 /PRNewswire/ -- A Public-private partnership resulted in the development of a new web-based tool that will
In vivo T cell active immunotherapy generated from DCVex(TM) platform SEATTLE and SOUTH SAN FRANCISCO, Calif., June 5, 2014 /PRNewswire/ -- Immune Design, a clinical-stage immunotherapy
Immunoglobulins or antibodies are proteins used by the immune system to neutralize pathogens including bacteria and viruses.
A study led by researchers at Stanford's School of Medicine reveals how T cells, the immune system's foot soldiers, respond to an enormous number of potential health threats.
SEATTLE and SAN FRANCISCO, May 27, 2014 /PRNewswire/ -- Immune Design, a clinical-stage immunotherapy company focused on the development of novel immune-based therapies for cancer and other
Our bodies produce a family of proteins that recognize and kill bacteria whose carbohydrate coatings resemble those of our own cells too closely.
The cause of neuronal death in Parkinson's disease is still unknown, but a new study proposes that neurons may be mistaken for foreign invaders and killed by the person's own immune system, similar to the way autoimmune diseases like type I diabetes, celiac disease, and multiple sclerosis attack the body's cells.
LONDON, April 11, 2014 /PRNewswire/ -- ThioBridge(TM) linker to attach different payloads to a range of antibodies PolyTherics Limited ("PolyTherics"),
- totally perplexed and mixed up.